The Fort Worth Press - Boomerang Ventures Portfolio Company Respiratory Health Technologies Secures Seed Capital to Accelerate Growth in Respiratory Wellness

USD -
AED 3.673042
AFN 63.503991
ALL 81.250403
AMD 376.940403
ANG 1.789731
AOA 917.000367
ARS 1398.425804
AUD 1.414027
AWG 1.8
AZN 1.70397
BAM 1.64926
BBD 2.014277
BDT 122.307345
BGN 1.647646
BHD 0.375226
BIF 2965
BMD 1
BND 1.264067
BOB 6.911004
BRL 5.219404
BSD 1.000055
BTN 90.587789
BWP 13.189806
BYN 2.866094
BYR 19600
BZD 2.011317
CAD 1.36155
CDF 2255.000362
CHF 0.767783
CLF 0.021854
CLP 862.903912
CNY 6.90865
CNH 6.901015
COP 3666.4
CRC 485.052916
CUC 1
CUP 26.5
CVE 93.303894
CZK 20.44504
DJF 177.720393
DKK 6.293504
DOP 62.27504
DZD 129.63704
EGP 46.615845
ERN 15
ETB 155.203874
EUR 0.842404
FJD 2.21204
FKP 0.733683
GBP 0.732547
GEL 2.67504
GGP 0.733683
GHS 11.01504
GIP 0.733683
GMD 73.503851
GNF 8780.000355
GTQ 7.67035
GYD 209.236037
HKD 7.81855
HNL 26.510388
HRK 6.348604
HTG 131.126252
HUF 319.430388
IDR 16832.8
ILS 3.09073
IMP 0.733683
INR 90.56104
IQD 1310.5
IRR 42125.000158
ISK 122.170386
JEP 0.733683
JMD 156.510227
JOD 0.70904
JPY 152.70604
KES 129.000351
KGS 87.450384
KHR 4022.00035
KMF 415.00035
KPW 899.945229
KRW 1440.710383
KWD 0.30661
KYD 0.833418
KZT 494.893958
LAK 21445.000349
LBP 89550.000349
LKR 309.225755
LRD 186.403772
LSL 15.945039
LTL 2.95274
LVL 0.60489
LYD 6.310381
MAD 9.141039
MDL 16.981212
MGA 4395.000347
MKD 51.914306
MMK 2099.574581
MNT 3581.569872
MOP 8.053972
MRU 39.920379
MUR 45.930378
MVR 15.405039
MWK 1736.503736
MXN 17.16435
MYR 3.907504
MZN 63.910377
NAD 15.960377
NGN 1353.403725
NIO 36.710377
NOK 9.506104
NPR 144.93218
NZD 1.655355
OMR 0.382709
PAB 1.000148
PEN 3.353039
PGK 4.293039
PHP 57.848504
PKR 279.603701
PLN 3.54775
PYG 6558.925341
QAR 3.64125
RON 4.291404
RSD 99.437038
RUB 76.275534
RWF 1455
SAR 3.750258
SBD 8.045182
SCR 13.479671
SDG 601.503676
SEK 8.922504
SGD 1.263604
SHP 0.750259
SLE 24.450371
SLL 20969.49935
SOS 571.503662
SRD 37.754038
STD 20697.981008
STN 20.85
SVC 8.750574
SYP 11059.574895
SZL 15.940369
THB 31.080369
TJS 9.435908
TMT 3.5
TND 2.84375
TOP 2.40776
TRY 43.649804
TTD 6.78838
TWD 31.384038
TZS 2600.000335
UAH 43.128434
UGX 3540.03196
UYU 38.554298
UZS 12150.000334
VES 392.73007
VND 25970
VUV 119.325081
WST 2.701986
XAF 553.151102
XAG 0.012937
XAU 0.000198
XCD 2.70255
XCG 1.802336
XDR 0.687473
XOF 553.000332
XPF 100.950363
YER 238.350363
ZAR 15.950904
ZMK 9001.203584
ZMW 18.176912
ZWL 321.999592
  • BCC

    -1.5600

    86.5

    -1.8%

  • CMSD

    0.0647

    23.64

    +0.27%

  • BCE

    -0.1200

    25.71

    -0.47%

  • GSK

    0.3900

    58.93

    +0.66%

  • BTI

    -1.1100

    59.5

    -1.87%

  • RBGPF

    0.1000

    82.5

    +0.12%

  • AZN

    1.0300

    205.55

    +0.5%

  • CMSC

    0.0500

    23.75

    +0.21%

  • JRI

    0.2135

    13.24

    +1.61%

  • RIO

    0.1600

    98.07

    +0.16%

  • BP

    0.4700

    37.66

    +1.25%

  • VOD

    -0.0500

    15.57

    -0.32%

  • NGG

    1.1800

    92.4

    +1.28%

  • RYCEF

    0.2300

    17.1

    +1.35%

  • RELX

    2.2500

    31.06

    +7.24%

Boomerang Ventures Portfolio Company Respiratory Health Technologies Secures Seed Capital to Accelerate Growth in Respiratory Wellness
Boomerang Ventures Portfolio Company Respiratory Health Technologies Secures Seed Capital to Accelerate Growth in Respiratory Wellness

Boomerang Ventures Portfolio Company Respiratory Health Technologies Secures Seed Capital to Accelerate Growth in Respiratory Wellness

Aims to Disrupt $11B Wellness and Respiratory Health Market

Text size:

INDIANAPOLIS, IN, NY / ACCESS Newswire / October 9, 2025 / Boomerang Ventures today announced that portfolio company Respiratory Health Technologies has successfully closed its seed financing round, marking a significant milestone for both the Boomerang Studio and Boomerang Fund. The investment round was led by Wellington Group Ventures, with participation from Boomerang VC Fund I, LP, underscoring the strength of Boomerang's integrated studio-fund model in advancing connected health innovations.

Respiratory Health Technologies, an Indianapolis-based respiratory wellness company, is pioneering a new approach to sinus health with SinuSauna®, the first doctor-invented at-home respiratory wellness device that uses heated dry-air therapy-rather than steam or saline to relieve congestion naturally. Since its national debut in 2024, SinuSauna has gained traction among consumers seeking safe, effective, and drug-free solutions for their sinus care needs.

A Milestone for Boomerang's Studio-Fund Model

The completion of Respiratory Health Technologies' seed financing reflects the success of Boomerang's unique approach, which combines a venture studio with a venture fund to accelerate healthcare innovation.

"Respiratory Health Technologies' seed raise is a powerful validation of the Boomerang model," said Eric Beier, MD, Partner and Chief Medical Officer of Boomerang Ventures. "Through the structured derisking and business building in our venture studio matched with pre-seed and seed funding from our venture fund, we've helped Respiratory Health Technologies bring an innovative product to market and secure the capital needed to scale. This achievement demonstrates how an integrated approach can accelerate solutions that make a real impact in healthcare."

Fueling Growth and Expanding Access

The seed funding will enable Respiratory Health Technologies to expand market presence, drive product development, and build national brand awareness in the $11B respiratory wellness market. Nearly 50% of Americans suffer from nasal congestion, underscoring the vast and ongoing need for effective solutions.

"Closing this round allows us to build on our momentum and provides a real opportunity to disrupt the respiratory wellness space by delivering drug-free sinus relief to more people than ever before," said Nancy Wright, CEO and Co-Founder of Respiratory Health Technologies. "Boomerang's partnership has been instrumental in helping us move from idea to commercialization.

Investor Support

"Wellington Group Ventures seeks out companies with defensible innovation and the ability to execute at scale," said Tony Bonanno, Managing member at Wellington Group Ventures. "Respiratory Health Technologies is exactly that - a team with vision, a patent-protected solution, and momentum in a large and expanding market. We are excited to support their long-term growth journey."

About Boomerang Ventures

Founded in 2019, Boomerang Ventures is a venture capital firm focused on early growth-stage connected health technology companies. Leveraging a combination studio and venture fund, Boomerang provides the collaborative direction, deep industry expertise, and continuum of support founders need to take their innovations from ideation to market. Boomerang believes that better patient care begins with identifying and solving the biggest challenges in healthcare. Boomerang Ventures is proudly and strategically based in Indianapolis, where the healthcare and entrepreneurial business climate is a thriving community ripe with opportunities. With a secure niche at the intersection of health technology, studio-fund synchronization, and the Midwest, Boomerang differentiates itself from the competition. Boomerang Ventures is Healthcare Innovation, Reimagined. For more information, visit Boomerang.vc.

About Respiratory Health Technologies

Respiratory Health Technologies is an Indianapolis-based wellness CPG company dedicated to developing innovative, drug-free solutions for respiratory care. Its flagship product, SinuSauna, combines medical insight with user-focused design to help people breathe better, naturally. Learn more at sinusauna.com.

About Wellington Group Ventures

Wellington Group Ventures is the venture capital arm of The Wellington Group. Founded in 1996, The Wellington Group is a boutique wealth management firm dedicated to aligning financial strategies with each client's unique purpose. Serving individuals, families, business owners, and high-net-worth clients, the firm specializes in retirement planning, tax efficiency, legacy building, and business succession. Proudly based in Indianapolis, The Wellington Group combines deep expertise with a personalized approach, helping clients navigate complexity and live with financial confidence. For more information, visit thewellingtongroupllc.com.

# # #

Media Contact:
Audra Wait | Wait & Co. on behalf of Boomerang Ventures
[email protected] | 615.504.8812

SOURCE: Boomerang Ventures



View the original press release on ACCESS Newswire

S.Rocha--TFWP